Literature DB >> 279205

Clinical limitations and advantages of transcutaneous oxygen electrodes.

J L Peabody, M M Willis, G A Gregory, W H Tooley, J F Lucey.   

Abstract

We investigated the clinical use and limitations of the transcutaneous oxygen electrode described by Huch, Lübbers and Huch in 30 sick infants. One hundred and fifty-nine measurements of arterial oxygen tension (PaO2) and transcutaneous oxygen tension (tcPO2) were made. During the comparisons, arterial blood pressures, heart rate thoracic impedance were continuously recorded, skin axillary and environmental temperatures, hematocrit and skin thickness were measureed and the degree of peripheral perfusion noted. Despite a wide range of these variables, values of tcPO2 and PaO2 were similar (slope 0.963). Two groups of infants were identified in whom tcPO2 was lower than PaO2. These were infants receiving an intravascular infusion of tolazoline and infants with mean arterial blood pressures more than 2.5 s.d. below the predicted average value. Both of these situations represent extreme alterations in peripheral blood flow and give important information regarding the limitations of the method. Less extreme alterations in flow caused by mild hypotension, hypothermia, anemia, radiant warmers, and bilirubin lights did not adversely affect the transcutaneous PO2--arterial PO2 correlation. Advantages of transcutaneous oxygen monitoring over more conventional monitoring methods were assessed. We conclude that the transcutaneous oxygen electrode is safe, is easy to use, has few limitations and provides data which can help improve the management of most sick infants.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 279205     DOI: 10.1111/j.1399-6576.1978.tb01397.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand Suppl        ISSN: 0515-2720


  10 in total

1.  Vascular volume monitoring with pulse oximetry during paediatric anaesthesia.

Authors:  D J James; R E Brown
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

2.  Solid MRI contrast agents for long-term, quantitative in vivo oxygen sensing.

Authors:  Vincent H Liu; Christophoros C Vassiliou; Syed M Imaad; Michael J Cima
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

3.  Transcutaneous oxygen monitoring in an infant undergoing tracheoesophageal fistula repair.

Authors:  M J Bautista; B S Kuwahara; C U Henderson
Journal:  Can Anaesth Soc J       Date:  1986-07

4.  Evaluation of transcutaneous oxygen tension monitoring during cosmetic surgery.

Authors:  R Riefkohl; E B Cox; R Kosanin; A H Beder
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

5.  Predicting stump healing following amputation for peripheral vascular disease using the transcutaneous oxygen monitor.

Authors:  G S Dowd
Journal:  Ann R Coll Surg Engl       Date:  1987-01       Impact factor: 1.891

6.  Toe temperature versus transcutaneous oxygen tension monitoring during acute circulatory failure.

Authors:  J L Vincent; J J Moraine; P van der Linden
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Spectrophotometric monitoring of arterial oxygen saturation in the fingertip.

Authors:  I Yoshiya; Y Shimada; K Tanaka
Journal:  Med Biol Eng Comput       Date:  1980-01       Impact factor: 2.602

Review 8.  Transcutaneous PO2 measurement.

Authors:  K K Tremper
Journal:  Can Anaesth Soc J       Date:  1984-11

9.  Photoluminescent oxygen-release microspheres to image the oxygen release process in vivo.

Authors:  Ya Guan; Hong Niu; Yu Dang; Ning Gao; Jianjun Guan
Journal:  Acta Biomater       Date:  2020-08-25       Impact factor: 8.947

Review 10.  Oxygen Supplementation During Preterm Stabilization and the Relevance of the First 5 min After Birth.

Authors:  Inmaculada Lara-Cantón; Alvaro Solaz; Anna Parra-Llorca; Ana García-Robles; Ivan Millán; Isabel Torres-Cuevas; Maximo Vento
Journal:  Front Pediatr       Date:  2020-01-31       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.